USC.edu
Are You a Patient?

Andrew Mellor

Clinical Operations Project Manager

Image of Andrew Mellor
Is this your profile? Click to edit
Email [email protected]
CTSI Profile

Publications

  • Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis. Front Immunol. 2020; 11:1256.. View in PubMed
  • CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8+ T Cells Formation and Human Papilloma Virus (HPV)-Positive Tumor Eradication. Front Immunol. 2020; 11:1012.. View in PubMed
  • CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint. Nat Commun. 2020 01 24; 11(1):515.. View in PubMed
  • Stimulator of interferon genes agonists attenuate type I diabetes progression in NOD mice. Immunology. 2019 12; 158(4):353-361.. View in PubMed
  • A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non-Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease. Clin Cancer Res. 2020 01 01; 26(1):282-289.. View in PubMed
  • Limited Effect of Indolamine 2,3-Dioxygenase Expression and Enzymatic Activity on Lupus-Like Disease in B6.Nba2 Mice. Front Immunol. 2019; 10:2017.. View in PubMed
  • Adoptive CD8+ T cell therapy against cancer:Challenges and opportunities. Cancer Lett. 2019 Oct 10; 462:23-32.. View in PubMed
  • IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation. Int Immunol. 2019 03 05; 31(3):181-182.. View in PubMed
  • Immune control by amino acid catabolism during tumorigenesis and therapy. Nat Rev Cancer. 2019 03; 19(3):162-175.. View in PubMed
  • Metabolic requirements for expanding and arming a clone army. Nat Immunol. 2019 02; 20(2):118-120.. View in PubMed

Similar People